Immunoglobulin A (IgA) Nephropathy
3 clinical trials · Condition
◉ Watch Immunoglobulin A (IgA) Nephropathy
| Record | Firm | Date |
|---|---|---|
| Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (NCT05065970) | HI-Bio, A Biogen Company | 2021-08-31 |
Track Immunoglobulin A (IgA) Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.